progabide has been researched along with Parkinson Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergmann, KJ; Limongi, JC; Lowe, YH; Mendoza, MR; Yahr, MD | 1 |
Christensen, SE; Dupont, E; Mondrup, K; Olivarius, BF; Orskov, H | 1 |
Marsden, CD; Sheehy, MP | 1 |
Bartholini, G | 1 |
Bartholini, G; Lloyd, KG; Scatton, B; Zivkovic, B | 1 |
Lheroux, A; Luquin, MR; Martinez Lage, JM; Obeso, JA; Scatton, B | 1 |
Bennett, JP; Cruz, CJ; Ferrari, MB | 1 |
2 trial(s) available for progabide and Parkinson Disease
Article | Year |
---|---|
Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist.
Topics: Anticonvulsants; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; gamma-Aminobutyric Acid; Humans; Levodopa; Parkinson Disease; Receptors, Cell Surface; Receptors, GABA-A | 1984 |
GABA and movement disorders.
Topics: Anticonvulsants; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Isoniazid; Movement Disorders; Muscimol; Parkinson Disease; Valproic Acid | 1981 |
5 other study(ies) available for progabide and Parkinson Disease
Article | Year |
---|---|
Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
Topics: Adult; Aged; Alzheimer Disease; Atrophy; Brain Diseases; Female; gamma-Aminobutyric Acid; Humans; Huntington Disease; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Peptides; Tremor | 1984 |
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Topics: 4-Aminobutyrate Transaminase; Basal Ganglia Diseases; Bicuculline; Dopamine; Dyskinesia, Drug-Induced; Epilepsy; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Limbic System; Neural Pathways; Neurons; Neurotransmitter Agents; Parkinson Disease; Psychopharmacology | 1979 |
GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease.
Topics: Acetylcholine; Animals; Antiparkinson Agents; Cholinergic Fibers; Corpus Striatum; Dopamine; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Motor Skills; Parkinson Disease; Receptors, Dopamine; Receptors, GABA-A; Synapses; Synaptic Transmission | 1987 |
Progabide in Parkinson's disease.
Topics: gamma-Aminobutyric Acid; Humans; Parkinson Disease | 1987 |
GABA-mimetic drugs enhance apomorphine-induced contralateral turning in rats with unilateral nigrostriatal dopamine denervation: implications for the therapy of Parkinson's disease.
Topics: Alkynes; Aminocaproates; Animals; Antiparkinson Agents; Apomorphine; Drug Synergism; gamma-Aminobutyric Acid; Isoxazoles; Male; Motor Activity; Nicotinic Acids; Parkinson Disease; Rats; Rats, Inbred Strains | 1987 |